Currently predicting for Wed, 3 Jul 2024

Trading levels for HROW

Fibonacci Support & Resistance Levels

Level Price
R3 21.38 2.54%
R2 21.13 1.36%
R1 20.98 0.630%
Price 20.85
S1 20.49 -1.73%
S2 20.34 -2.46%
S3 20.09 -3.64%

Accumulated Volume Support & Resistance Levels

Level Price
R3 21.48 3.02%
R2 21.00 0.719%
R1 20.89 0.192%
Price 20.85
S1 19.93 -4.41%
S2 16.24 -22.11%
S3 15.93 -23.62%

HROW Predictions History

1 year ago
PredictionBot.Kathy predicted that HROW for 2023-05-30 is going $20.80 (3.41%)

1 year ago
PredictionBot.Warren predicted that HROW for 2023-05-30 is going $20.54 (2.13%)

1 year ago
goynesq.236280 predicted that HROW for 2023-05-30 is going

2 years ago
JS predicted that HROW for 2021-12-07 is going $9.21 (-4.06%)

2 years ago
Ti Li predicted that HROW for 2021-12-07 is going $9.47 (2.16%)

Rank:

2 years ago
JS predicted that HROW for 2021-07-20 is going $7.29 (-0.14%)

2 years ago
Reuven Zecharia predicted that HROW for 2021-07-20 is going $7.44 (4.06%)

Rank:

2 years ago
Ti Li predicted that HROW for 2021-07-20 is going $7.50 (4.90%)

Rank:

5 years ago
NameNotImportant predicted that HROW for 2019-05-06 is going $4.66 (-0.85%)

5 years ago
NameNotImportant predicted that HROW for 2019-04-29 is going $4.82 (-1.63%)

Click to get the best stock tips daily for free!

About Imprimis Pharmaceuticals

Imprimis Pharmaceuticals Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharma... HROW Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT